[Federal Register Volume 72, Number 98 (Tuesday, May 22, 2007)]
[Notices]
[Page 28704]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 07-2541]



[[Page 28704]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Comprehensive Minority Institution Cancer Center Partnership.
    Date: June 10-12, 2007.
    Time: 7 p.m. to 11 p.m. (June 10), 8 a.m. to 5 p.m. (June 11 and 
12).
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 
20814.
    Contact Person: Gerald G. Lovinger, PhD, Scientific Review 
Administrator, Special Review and Logistics Branch, Division of 
Extramural Activities, National Cancer Institute, 6116 Executive 
Blvd., Room 8101, Bethesda, MD 20892-8329, 301-496-7897, 
<a href="/cdn-cgi/l/email-protection#fa96958c93949d9f9dba979b9396d4949392d49d958c"><span class="__cf_email__" data-cfemail="5f3330293631383a381f323e36337131363771383029">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Clinical Studies Special Emphasis Panel.
    Date: June 18-19, 2007.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 
20814.
    Contact Person: Majed M. Hamawy, PhD, MBA, Scientific Review 
Administrator, Research Programs Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 6116 
Executive Blvd., Room 8135, Bethesda, MD 20852, 301-594-5659, 
<a href="/cdn-cgi/l/email-protection#6e03065f5e5f182e00070640090118"><span class="__cf_email__" data-cfemail="5934316869682f19373031773e362f">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Cancer Sample Preparation/Detection and Diagnosis.
    Date: June 21, 2007.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Gaithersburg Hilton, 620 Perry Parkway, Gaithersburg, MD 
20877.
    Contact Person: Lalita D. Palekar, PhD, Scientific Review 
Administrator, Special Review and Logistics Branch, Division of 
Extramural Activities, National Cancer Institute, 6116 Executive 
Blvd., Room 7141, Bethesda, MD 20892-7405, 301-496-7575, 
<a href="/cdn-cgi/l/email-protection#bdcddcd1d8d6dccfd1fdd0dcd4d193d3d4d593dad2cb"><span class="__cf_email__" data-cfemail="a2d2c3cec7c9c3d0cee2cfc3cbce8ccccbca8cc5cdd4">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Innovations in Cancer Sample Preparation.
    Date: June 21, 2007.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Gaithersburg Hilton, 620 Perry Parkway, Gaithersburg, MD 
20877.
    Contact Person: Lalita D. Palekar, PhD, Scientific Review 
Administrator, Special Review and Logistics Branch, Division of 
Extramural Activities, National Cancer Institute, 6116 Executive 
Blvd., Room 7141, Bethesda, MD 20892-7405, 301-496-7575, 
<a href="/cdn-cgi/l/email-protection#f88899949d93998a94b895999194d6969190d69f978e"><span class="__cf_email__" data-cfemail="b4c4d5d8d1dfd5c6d8f4d9d5ddd89adadddc9ad3dbc2">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Early Clinical Trials of New Anti-Cancer Agents with Phase I 
Emphasis (U01).
    Date: July 10-11, 2007.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Marriott Bethesda Suites, 6711 Democracy Blvd., Bethesda, 
MD 20817.
    Contact Person: C. Michael Kerwin, PhD, MPH, Scientific Review 
Administrator, Special Review and Logistics Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 6116 
Executive Blvd., Room 8057, Bethesda, MD 20892-8329, 301-496-7421, 
<a href="/cdn-cgi/l/email-protection#09626c7b7e606764496468606527676061276e667f"><span class="__cf_email__" data-cfemail="d8b3bdaaafb1b6b598b5b9b1b4f6b6b1b0f6bfb7ae">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: May 15, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-2541 Filed 5-21-07; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>